“Mira Pharmaceuticals Rises 4.9% as Pre‑clinical MIRA‑55 Shows Promising Pain Relief Results”
New pre‑clinical data shows Mira Pharmaceuticals’ MIRA‑55 matches celecoxib’s pain relief, no tolerance, and dual anti‑inflammatory effect, paving the way for a 2027 IND filing.
- MIRA PHARMACEUTICALS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read